Score Breakdown
Offering Ability
80
Cash Runway
0
Float Risk
100
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 5%
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (62/100)
Market Data
Market Cap$1.73B
Shares Outstanding61.74M
Float1.05M
Cash$576.50M
Debt$72.0K
Short InterestN/A
Institutional Holdings
67 institutional holders · 59.68M shares
#1
FMR LLC
9.05M shares
#2
Fairmount Funds Management LLC
8.71M shares
#3
Remedium Capital Partners, LLC
4.09M shares
+ 17 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2020-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual GLTO Dilution Snapshot
Damora Therapeutics, Inc. (GLTO) has a DilutionScore of 62/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for GLTO: xbrl on 2020-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: